日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2Rα

抗原-IL-2 CAR增强子驱动CAR-T细胞的命运和干性,增强其在各种模型中的抗肿瘤疗效,且该作用独立于IL-2Rα。

Moravej, Heydar; Rakhshandehroo, Taha; Khan, Radia M M; Rivet, Victoria Marie; Marcandalli, Elodie; Mantri, Shreya R; Taklifi, Pegah; Lee, Uk-Jae; Louis, Benjamin B V; Munaretto, Leila A; Regan, Kathryn; Farkash, Zoe; Berland, Lea; Gabr, Zeina; Wolff, Alexandra N; Kowalewski, Antonia; Allen, Harris H; Nili, Ali; Baral, Jessika; Mercadante, Dayna; Fulciniti, Mariateresa; Jacobson, Caron A; Sperling, Adam S; Nadeem, Omar; Nia, Hadi T; Hemann, Michael; Munshi, Nikhil C; Rashidian, Mohammad

Dual PD-1/IL-2Rα targeting restores CD8(+) T cell fitness via STAT5/CD47 axis in SMARCA4-deficient NSCLC.

双重 PD-1/IL-2Rα 靶向治疗通过 STAT5/CD47 轴恢复 SMARCA4 缺陷型 NSCLC 中的 CD8(+) T 细胞功能。

Reshape the Fates of Treg and CD8+T Cells Through IL-2Rα by Synergizing Divergent Receptor-Biased IL-2 PEGylates

通过协同作用不同的受体偏向性IL-2聚乙二醇化物,重塑Treg细胞和CD8+T细胞的命运,其途径涉及IL-2Rα。

Sun, Jiaqi; Guo, Lingfeng; Ji, Dezhong; Yu, Mengfan; Cheng, Boyang; Zhu, Xingxing; Yuan, Yeshuang; Wu, Siyu; Zhang, Yuanjie; Shi, Wen; Chen, Zhiqian; Chu, Xindang; Hu, Jiayu; Hua, Liwen; Wang, Yiming; Zhu, Yanning; Mu, Yu; Sun, Hanwen; Zhang, Chuanling; Wang, Qi; Xiao, Sulong; Zhang, Lihe; Zhang, Bo; Zhou, Demin

IL-2Rα is a potential biomarker for heart failure diagnosis of patients with end-stage renal disease and haemodialysis

IL-2Rα 是终末期肾病和血液透析患者心力衰竭诊断的潜在生物标志物。

Lv, Bingya; Wang, Zhe; Suo, Ya; Shao, Shuai; Yuan, Meng; Zhang, Yue; Wang, Lihua; Li, Guangping; Bao, Qiankun

IL-2Rα is dispensable for murine B cell development and humoral response.

IL-2Rα对于小鼠B细胞发育和体液免疫反应并非必需。

Adherent Natural Killer Cells De Novo Express IL-2Rα and Sustain Long-Lasting, Potent Anti-Tumor Activity in Picomolar Concentrations of IL-2

黏附性自然杀伤细胞从头表达IL-2Rα,并在皮摩尔浓度的IL-2中维持持久、强效的抗肿瘤活性

Vujanovic, Nikola L; Vujanovic, Lazar; Whiteside, Theresa L

A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies

一种靶向PD-1、受体掩蔽的IL-2免疫细胞因子,可通过与IL-2Rα结合来增强T细胞介导的抗肿瘤疗法。

Jiaxi Wu ,Nicolin Bloch ,Aaron Y Chang ,Ramandeep Bhavsar ,Qingqing Wang ,Alison Crawford ,David J DiLillo ,Kristin Vazzana ,Katja Mohrs ,Drew Dudgeon ,Supriya Patel ,Hassan Ahmed ,Vidur Garg ,Michael Amatulli ,Olivia Q Antao ,Yuetian Yan ,Shunhai Wang ,Willy Ramos ,Pamela Krueger ,Christina Adler ,Min Ni ,Yi Wei ,Chunguang Guo ,Lynn Macdonald ,Tammy Huang ,Erica Ullman ,Aynur Hermann ,George D Yancopoulos ,Andrew J Murphy ,Samuel Davis ,William C Olson ,John C Lin ,Eric Smith ,Tong Zhang

Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species

斑蝥素通过活性氧克服皮肤T细胞淋巴瘤中IL-2Rα信号介导的伏立诺他耐药性

Zhu, Man; Tang, Wenjun; Tang, Xiaoyu; Zhu, Zeren; Jiang, Yina; Sarwar, Ammar; Zhang, Hongmei; Chu, Dake; Zhang, Zixi; Zhang, Yanmin

Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity

IL-2 与 IL-2Rα 的邻近共价结合可选择性地激活调节性 T 细胞并抑制自身免疫。

Bo Zhang # ,Jiaqi Sun # ,Yeshuang Yuan # ,Dezhong Ji # ,Yeting Sun # ,Yudong Liu ,Shengjie Li ,Xingxing Zhu ,Xunyao Wu ,Jin Hu ,Qiu Xie ,Ling Wu ,Lulu Liu ,Boyang Cheng ,Yuanjie Zhang ,Lingjuan Jiang ,Lidan Zhao ,Fei Yu ,Wei Song ,Min Wang ,Yue Xu ,Shiliang Ma ,Yunyun Fei ,Lihe Zhang ,Demin Zhou ,Xuan Zhang

Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke

血浆IL-2和sIL-2Rα在首次发生缺血性卒中患者中的预后意义

Zhao, Haiping; Li, Fangfang; Huang, Yuyou; Zhang, Sijia; Li, Lingzhi; Yang, Zhenhong; Wang, Rongliang; Tao, Zhen; Han, Ziping; Fan, Junfen; Zheng, Yangmin; Ma, Qingfeng; Luo, Yumin